301 related articles for article (PubMed ID: 35882062)
1. Inhibition of AHNAK nucleoprotein 2 alleviates pulmonary fibrosis by downregulating the TGF-β1/Smad3 signaling pathway.
Zhu D; Zhang Q; Li Q; Wang G; Guo Z
J Gene Med; 2022 Sep; 24(9):e3442. PubMed ID: 35882062
[TBL] [Abstract][Full Text] [Related]
2. AHNAK2 Promotes Migration, Invasion, and Epithelial-Mesenchymal Transition in Lung Adenocarcinoma Cells via the TGF-β/Smad3 Pathway.
Liu G; Guo Z; Zhang Q; Liu Z; Zhu D
Onco Targets Ther; 2020; 13():12893-12903. PubMed ID: 33363388
[TBL] [Abstract][Full Text] [Related]
3. p90RSK Inhibition Ameliorates TGF-β1 Signaling and Pulmonary Fibrosis by Inhibiting Smad3 Transcriptional Activity.
Kim S; Han JH; Kim S; Lee H; Kim JR; Lim JH; Woo CH
Cell Physiol Biochem; 2020 Feb; 54(2):195-210. PubMed ID: 32083406
[TBL] [Abstract][Full Text] [Related]
4. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
5. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
6. Low-dose paclitaxel ameliorates pulmonary fibrosis by suppressing TGF-β1/Smad3 pathway via miR-140 upregulation.
Wang C; Song X; Li Y; Han F; Gao S; Wang X; Xie S; Lv C
PLoS One; 2013; 8(8):e70725. PubMed ID: 23967091
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of mTOR ameliorates bleomycin-induced pulmonary fibrosis by regulating epithelial-mesenchymal transition.
Han Q; Lin L; Zhao B; Wang N; Liu X
Biochem Biophys Res Commun; 2018 Jun; 500(4):839-845. PubMed ID: 29704504
[TBL] [Abstract][Full Text] [Related]
8. Total flavonoids of Oxytropis falcata Bunge have a positive effect on idiopathic pulmonary fibrosis by inhibiting the TGF-β1/Smad signaling pathway.
Li XZ; Wang XL; Wang YJ; Liang QK; Li Y; Chen YW; Ming HX
J Ethnopharmacol; 2022 Mar; 285():114858. PubMed ID: 34826543
[TBL] [Abstract][Full Text] [Related]
9. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP).
Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z
J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478
[TBL] [Abstract][Full Text] [Related]
10. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-{beta}1 induces Smad3-dependent {beta}1 integrin gene expression in epithelial-to-mesenchymal transition during chronic tubulointerstitial fibrosis.
Yeh YC; Wei WC; Wang YK; Lin SC; Sung JM; Tang MJ
Am J Pathol; 2010 Oct; 177(4):1743-54. PubMed ID: 20709799
[TBL] [Abstract][Full Text] [Related]
12. Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway.
Zhang Y; Lu YB; Zhu WJ; Gong XX; Qian R; Lu YJ; Li Y; Yao WF; Bao BH; Zhang Y; Zhang L; Cheng FF
J Ethnopharmacol; 2024 Apr; 324():117737. PubMed ID: 38228229
[TBL] [Abstract][Full Text] [Related]
13. miR-184 targets TP63 to block idiopathic pulmonary fibrosis by inhibiting proliferation and epithelial-mesenchymal transition of airway epithelial cells.
Li J; Pan C; Tang C; Tan W; Zhang W; Guan J
Lab Invest; 2021 Feb; 101(2):142-154. PubMed ID: 32989231
[TBL] [Abstract][Full Text] [Related]
14. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z
J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194
[TBL] [Abstract][Full Text] [Related]
15. CXCL9 Regulates TGF-β1-Induced Epithelial to Mesenchymal Transition in Human Alveolar Epithelial Cells.
O'Beirne SL; Walsh SM; Fabre A; Reviriego C; Worrell JC; Counihan IP; Lumsden RV; Cramton-Barnes J; Belperio JA; Donnelly SC; Boylan D; Marchal-Sommé J; Kane R; Keane MP
J Immunol; 2015 Sep; 195(6):2788-96. PubMed ID: 26268659
[TBL] [Abstract][Full Text] [Related]
16. All-transretinoic acid ameliorates bleomycin-induced lung fibrosis by downregulating the TGF-β1/Smad3 signaling pathway in rats.
Song X; Liu W; Xie S; Wang M; Cao G; Mao C; Lv C
Lab Invest; 2013 Nov; 93(11):1219-31. PubMed ID: 24042439
[TBL] [Abstract][Full Text] [Related]
17. Exogenous angiotensin (1-7) directly inhibits epithelial-mesenchymal transformation induced by transforming growth factor-β1 in alveolar epithelial cells.
Shao M; Wen ZB; Yang HH; Zhang CY; Xiong JB; Guan XX; Zhong WJ; Jiang HL; Sun CC; Luo XQ; He XF; Zhou Y; Guan CX
Biomed Pharmacother; 2019 Sep; 117():109193. PubMed ID: 31387171
[TBL] [Abstract][Full Text] [Related]
18. Neohesperidin inhibits TGF-β1/Smad3 signaling and alleviates bleomycin-induced pulmonary fibrosis in mice.
Guo J; Fang Y; Jiang F; Li L; Zhou H; Xu X; Ning W
Eur J Pharmacol; 2019 Dec; 864():172712. PubMed ID: 31586469
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells.
Wang X; Gao JL; Zhao MM; Zhu HX; Tian YX; Li R; Jiang XH; Yu L; Tian JR; Cui JZ
Int J Mol Med; 2018 Feb; 41(2):659-668. PubMed ID: 29207055
[TBL] [Abstract][Full Text] [Related]
20. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]